{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:59:30Z","timestamp":1792519170142,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.berh.2024.102022","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T12:35:42Z","timestamp":1732106142000},"page":"102022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-9518","authenticated-orcid":false,"given":"Takehiro","family":"Nakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumasa","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2024.102022_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-023-03251-z","article-title":"Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort","volume":"26","author":"Fujii","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.102022_bib2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/14397595.2019.1661592","article-title":"Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study","volume":"30","author":"Tsuda","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12016-017-8653-0","article-title":"Neonatal systemic lupus erythematosus syndrome: a comprehensive review","volume":"53","author":"Vanoni","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.berh.2024.102022_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11926-009-0007-3","article-title":"Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes","volume":"11","author":"Gladd","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2024.102022_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41584-019-0351-2","article-title":"Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity","volume":"16","author":"F\u00f6rger","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003762","article-title":"Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study","volume":"10","author":"Pina Vegas","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102022_bib7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1177\/09612033211016074","article-title":"Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: a single-center retrospective analysis","volume":"30","author":"Nakai","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.102022_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101860","article-title":"Pregnancy in systemic lupus erythematosus","volume":"37","author":"Zucchi","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semarthrit.2019.03.011","article-title":"Obstetric outcomes in women with rheumatoid arthritis: results from nationwide inpatient Sample database 2003\u20132011","volume":"49","author":"Kishore","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102022_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10995-006-0073-3","article-title":"Pregnancy outcomes in women with rheumatoid arthritis in Washington State","volume":"10","author":"Reed","year":"2006","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.berh.2024.102022_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002445","article-title":"Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark","volume":"8","author":"Secher","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102022_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10067-022-06436-0","article-title":"Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis","volume":"42","author":"Huang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059203","article-title":"Fetal-neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study","volume":"12","author":"Tsai","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.berh.2024.102022_bib14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/eurheartj\/ehae108","article-title":"Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis","volume":"45","author":"Zahid","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2024.102022_bib15","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1093\/rheumatology\/keab894","article-title":"Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark","volume":"61","author":"Hellgren","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10067-019-04450-3","article-title":"Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers","volume":"38","author":"Shimada","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3899\/jrheum.141553","article-title":"Miscarriage and stillbirth in women with rheumatoid arthritis","volume":"42","author":"Wallenius","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13075-024-03298-6","article-title":"Effect of remission, clinical remission with active serology, and glucocorticoid dosage on the pregnancy outcome of pregnant patients with systemic lupus erythematosus","volume":"26","author":"Nakai","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.102022_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-023-06033-2","article-title":"Association between disease activity of rheumatoid arthritis and maternal and fetal outcomes in pregnant women: a systematic review and meta-analysis","volume":"23","author":"Lv","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.berh.2024.102022_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.887462","article-title":"Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis","volume":"13","author":"Gerardi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.berh.2024.102022_bib21","first-page":"1","article-title":"Updated methodology to estimate overall and unintended pregnancy rates in the United States: data evaluation and methods research","volume":"vol. 2","author":"Rossen","year":"2023"},{"key":"10.1016\/j.berh.2024.102022_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/humrep\/dev148","article-title":"Realizing a desired family size: when should couples start?","volume":"30","author":"Habbema","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.berh.2024.102022_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMp048087","article-title":"Advanced maternal age-how old is too old?","volume":"351","author":"Heffner","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.102022_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-14881-4","article-title":"Cigarette smoking during pregnancy and adverse perinatal outcomes: a cross-sectional study over 10 years","volume":"22","author":"Tarasi","year":"2022","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.berh.2024.102022_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tem.2019.11.004","article-title":"Impacts of caffeine during pregnancy","volume":"31","author":"Qian","year":"2020","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.berh.2024.102022_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.788630","article-title":"Intersection of epigenetic and immune alterations: implications for fetal alcohol spectrum disorder and mental health","volume":"15","author":"Lussier","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.berh.2024.102022_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Moise","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.102022_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/1744666X.2023.2197212","article-title":"The management of women of childbearing age with rheumatoid arthritis: an expert report","volume":"19","author":"Tanaka","year":"2023","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.102022_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/acr2.11043","article-title":"Reduced ovarian function in female rheumatoid arthritis patients trying to conceive","volume":"1","author":"Brouwer","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib31","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2018-214619","article-title":"Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study","volume":"78","author":"N\u00f8rg\u00e5rd","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acr.21593","article-title":"Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus","volume":"64","author":"Clowse","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102022_bib34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/acr.20510","article-title":"Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies","volume":"63","author":"Micu","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102022_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.604866","article-title":"IL-6 but not TNF\u03b1 levels are associated with time to pregnancy in female rheumatoid arthritis patients with a wish to conceive","volume":"11","author":"Bongenaar","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.berh.2024.102022_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.09.004","article-title":"Paternal safety of anti-rheumatic medications","volume":"64","author":"Bermas","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.berh.2024.102022_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.21859","article-title":"Childbearing decisions and family size among women with rheumatoid arthritis","volume":"55","author":"Katz","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102022_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/rheumatology\/keg079","article-title":"Effects of rheumatoid arthritis on sexual activity and relationships","volume":"42","author":"Hill","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/humrep\/dep392","article-title":"Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception","volume":"25","author":"Jesam","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.berh.2024.102022_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034131","article-title":"Association between pregnant women with rheumatoid arthritis and preeclampsia: a systematic review and meta-analysis","volume":"102","author":"Tian","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.berh.2024.102022_bib41","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1093\/rheumatology\/keac262","article-title":"Changes to expert opinion in the use of antirheumatic drugs before and during pregnancy five years after EULAR: points to consider","volume":"61","author":"Ramoni","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib43","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1093\/rheumatology\/keac552","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice","volume":"62","author":"Schreiber","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib44","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-219547","article-title":"Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study","volume":"80","author":"Smeele","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-022-04986-4","article-title":"Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort","volume":"22","author":"Dathe","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.berh.2024.102022_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000682","article-title":"Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis","volume":"9","author":"Nakai","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2024.102022_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105491","article-title":"Glucocorticoids in rheumatoid arthritis: balancing benefits and harm by leveraging the therapeutic window of opportunity","volume":"90","author":"Doumen","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2024.102022_bib49","article-title":"Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study","volume":"382","author":"Yao","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2024.102022_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003739","article-title":"Medication utilisation trends during pregnancy and factors influencing adverse pregnancy outcomes in patients with rheumatoid arthritis","volume":"10","author":"Song","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102022_bib51","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reprotox.2019.05.066","article-title":"Fetal methotrexate syndrome: a systematic review of case reports","volume":"87","author":"Verberne","year":"2019","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.berh.2024.102022_bib53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/annrheumdis-2017-212078","article-title":"Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes","volume":"77","author":"B\u00e9rard","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib54","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hern\u00e1ndez-D\u00edaz","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.berh.2024.102022_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/14397595.2020.1719607","article-title":"Efficacy and safety of tacrolimus in patients with rheumatoid arthritis\u2013A systematic review and meta-analysis","volume":"31","author":"Kaneko","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3109\/s10165-012-0817-4","article-title":"Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study","volume":"23","author":"Tanaka","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/14397595.2017.1332471","article-title":"Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): post-marketing surveillance in Japan","volume":"28","author":"Takeuchi","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-022-06325-6","article-title":"Effect and safety profile of belimumab and tacrolimus combination therapy in thirty - three patients with systemic lupus erythematosus","author":"Nakai","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/1756-185X.13248","article-title":"Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors","volume":"21","author":"Naniwa","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-023-03256-8","article-title":"A retrospective analysis of the safety of tacrolimus use and its optimal cut-off concentration during pregnancy in women with systemic lupus erythematosus: study from two Japanese tertiary referral centers","volume":"26","author":"Nakai","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2024.102022_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/09612033221148334","article-title":"Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective single-center analysis in Japan","author":"Kitada","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.102022_bib62","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/all.14878","article-title":"Intrauterine exposure to immunosuppressants influences the development of postnatal allergic diseases","volume":"76","author":"Kohno","year":"2021","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.berh.2024.102022_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008686","article-title":"Electrocardiographic QT intervals in infants exposed to hydroxychloroquine throughout gestation","volume":"13","author":"Friedman","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.berh.2024.102022_bib64","doi-asserted-by":"crossref","first-page":"290.e1","DOI":"10.1016\/j.ajog.2020.09.007","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.berh.2024.102022_bib65","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/S2665-9913(23)00215-1","article-title":"Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases","volume":"5","author":"Schreiber","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41584-019-0240-8","article-title":"Stratifying management of rheumatic disease for pregnancy and breastfeeding","volume":"15","author":"Giles","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cyto.2008.11.008","article-title":"Differences in binding and effector functions between classes of TNF antagonists","volume":"45","author":"Arora","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.berh.2024.102022_bib68","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.berh.2024.102022_bib69","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.berh.2024.102022_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-TNF-\u03b1 during pregnancy","volume":"8","author":"Esteve-Sol\u00e9","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.102022_bib71","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/annrheumdis-2021-221036","article-title":"Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy","volume":"81","author":"Ghalandari","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib72","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/ard-2022-222679","article-title":"Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients' offspring","volume":"81","author":"Smeele","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032655","article-title":"Tumor necrosis factor inhibitor use increases birthweight in pregnant women with rheumatoid arthritis independently of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio","volume":"13","author":"Quaak","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.berh.2024.102022_bib74","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/apt.15971","article-title":"Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy","volume":"52","author":"Br\u00f6ms","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.berh.2024.102022_bib75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2015.06.016","article-title":"Pregnancy outcomes following exposure to abatacept during pregnancy","volume":"45","author":"Kumar","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102022_bib76","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/rheumatology\/kez100","article-title":"Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum","volume":"58","author":"Saito","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2016.05.004","article-title":"Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data","volume":"46","author":"Hoeltzenbein","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.102022_bib78","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/14397595.2016.1147405","article-title":"Pregnancy outcomes after exposure to tocilizumab: a retrospective analysis of 61 patients in Japan","volume":"26","author":"Nakajima","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib79","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1016\/S2665-9913(24)00124-3","article-title":"Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study","volume":"6","author":"Nana","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib80","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2169\/internalmedicine.9607-22","article-title":"A woman with rheumatoid arthritis who successfully delivered a healthy child with continuous administration of sarilumab throughout pregnancy","volume":"62","author":"Mizutani","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.berh.2024.102022_bib81","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.berh.2024.102022_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100149","article-title":"Placental transfer of tofacitinib in the ex vivo dual-side human placenta perfusion model","volume":"6","author":"Eliesen","year":"2024","journal-title":"Curr Res Toxicol"},{"key":"10.1016\/j.berh.2024.102022_bib83","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40264-016-0431-z","article-title":"Pregnancy outcomes in the tofacitinib safety databases for rheumatoid arthritis and psoriasis","volume":"39","author":"Clowse","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.berh.2024.102022_bib84","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-024-01454-0","article-title":"Pregnancy outcomes in patients treated with upadacitinib: analysis of data from clinical trials and postmarketing reports","author":"Mahadevan","year":"2024","journal-title":"Drug Saf"},{"key":"10.1016\/j.berh.2024.102022_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002194","article-title":"Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study","volume":"8","author":"Kemper","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.102022_bib86","first-page":"368","article-title":"Breastfeeding: common questions and answers","volume":"98","author":"Westerfield","year":"2018","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.berh.2024.102022_bib87","article-title":"Methylprednisolone concentrations in breast milk and serum of patients with multiple sclerosis treated with IV pulse methylprednisolone","volume":"197","author":"Zengin","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.berh.2024.102022_bib88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case Report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.berh.2024.102022_bib89","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ecco-jcc\/jjaa099","article-title":"Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease","volume":"14","author":"Park","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.berh.2024.102022_bib90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.102022_bib91","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102022_bib92","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/art.38519","article-title":"Rheumatoid arthritis during pregnancy and postnatal catch-up growth in the offspring","volume":"66","author":"De Steenwinkel","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.102022_bib93","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.berh.2024.102022_bib94","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/mp.2013.101","article-title":"Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder","volume":"18","author":"Brimberg","year":"2013","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.berh.2024.102022_bib95","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2015.11.024","article-title":"Attention-deficit\/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases","volume":"81","author":"Instanes","year":"2017","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.berh.2024.102022_bib96","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1017\/S0033291723000855","article-title":"Maternal rheumatoid arthritis and risk of autism in the offspring","volume":"53","author":"Yin","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.berh.2024.102022_bib97","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/acr.24223","article-title":"Association of rheumatoid arthritis in pregnancy with school performance of offspring: a Danish nationwide register-based study","volume":"73","author":"Knudsen","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102022_bib98","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/acr.23461","article-title":"Children born by women with rheumatoid arthritis and increased susceptibility for chronic diseases: a nationwide cohort study","volume":"70","author":"J\u00f8lving","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.102022_bib99","article-title":"Parental autoimmunity and offspring risks of rheumatic diseases: a nationwide population-based study","author":"Shao","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.102022_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcped.2024.100145","article-title":"Maternal autoimmune disease and its association with childhood cancer: a population-based case-control study in Denmark","volume":"3","author":"Orimoloye","year":"2024","journal-title":"EJC Paediatric Oncology"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:17:42Z","timestamp":1741897062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521694224000937"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.102022","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.102022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102022"}}